Chairman of the board
Corporate Vice President, Global Research Strategy and Operations
Novo Nordisk A/S
Søren Bregenholt is Corporate Vice President, Global Research Strategy and Operations at Novo Nordisk, and as such responsible for the company’s strategy and activities for securing access to external innovation, through commercial licensing, university collaboration and public private partnerships. In addition he is responsible for Novo Nordisk’s global R&D-based PhD and Post Doc programmes, as well as research-, innovation-, and educational policy.
Søren Bregenholt is a Danish native born in 1971. In 1995 Søren graduated from University of Copenhagen, and received his PhD in biomedical research in 2000 also from University of Copenhagen. After his post-doctoral research at the Pasteur institute, Paris France, Søren joined Novo Nordisk in 2001 as scientist and project manager. From 2002-2010 Søren held a number of management positions in the Danish biotech company Symphogen including the role as Chief Operating Officer with responsibility for the company’s research and development project portfolio. Søren joined Novo Nordisk in 2010 as Vice President and Head of Corporate Alliance Management.
Søren is the author/co-author of more than 50 scientific papers. He represents Novo Nordisk in various organizations including EFPIA and PhRMA